Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development, manufacture and sale of disposable medical devices. We provide different kinds of products, including: i) consumables (infusion sets, syringes, medical needle products, blood bags, pre-filled syringes, blood collection products and other consumables used); ii) bone materials and iii) blood purification consumables and equipment. The Company is the industrialization base of the achievements of the National High Technology Research and Development (863) Program of China, a national high-tech enterprise and a national enterprise technology center. The main production base of the Group is located in Weihai City, Shandong Province, the PRC.
ResearchHealthcare, Technology, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Dada group's revenue rose nearly 30% in the third quarter, and JD's "hour purchase" cont
Looking forward to the fourth quarter of 2021, dada Group expects its total revenue to be between 2 billion yuan and 2.1 billion yuan. On the premise that the last kilometer of dada express delivery service is consistent with the comparable basis, the total revenue in the fourth quarter of 2021 will achieve a year-on-year increase of 88% to 97%.
Nov 24, 2021 11:42 AM